Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Plasma cell 3Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 10Breast Neoplasms 10Prostatic Neoplasms 9Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Multiple Myeloma 3Lymphoma 3Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematopoietic and Lymphoid System Neoplasm 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Prostate Cancer Patients 1

Interventions

Dexamethasone 87daratumumab 49Lenalidomide 49pomalidomide 33Bortezomib 32Cyclophosphamide 31carfilzomib 25Calcium Dobesilate 21talquetamab 19fludarabine 18isatuximab 16iberdomide 16Magnetic Resonance Spectroscopy 16Specimen Handling 15Biopsy 14selinexor 12Melphalan 11belantamab mafodotin 10dexamethasone acetate 9dexamethasone 21-phosphate 8elotuzumab 7auricularum 7venetoclax 6tocilizumab 5fludarabine phosphate 5X-Rays 5Blood Specimen Collection 5ruxolitinib 4Methylprednisolone 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Multiple Myeloma × Interviews as Topic × Clear all
NCT06145581 2026-04-13

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

Mayo Clinic

Phase NA Recruiting
25 enrolled
Plasma cell

Multiple Myeloma

NCT07045727 2026-03-30

Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma

Mayo Clinic

Phase NA Recruiting
20 enrolled
Plasma cell

Multiple Myeloma

NCT06236373 2024-12-09

Survivorship

University of Modena and Reggio Emilia

Recruiting
45 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cell

Breast Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Colorectal Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡